about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesTemporal heterogeneity in blood supply in human tumor xenografts.Measurement of proliferation activity in human melanoma xenografts by magnetic resonance imaging.Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenograftsRadiation-induced changes in phosphorus T1 values in human melanoma xenografts studied by 31P-MRS.Comparative imaging of structure and metabolites in tumours.Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts.Tumor interstitial fluid pressure-a link between tumor hypoxia, microvascular density, and lymph node metastasisSunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts.Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressureDW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.Correlation of high lactate levels in head and neck tumors with incidence of metastasis.Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).Radiation and heat sensitivity of cells from two slowly growing human melanoma xenografts.Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity.Vascular structure of five human malignant melanomas grown in athymic nude miceGrowth rates or radiobiological hypoxia are not correlated with local metabolite content in human melanoma xenografts with similar vascular network.Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points.Oxygen tension and vascular density in human cervix carcinoma.Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRSIntertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imagingHypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenograftsTemporal heterogeneity in oxygen tension in human melanoma xenografts.Transient perfusion in human melanoma xenografts.Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue.31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times.Proton relaxation times and interstitial fluid pressure in human melanoma xenografts.Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma.
P50
Q26747144-596A2372-1B65-4967-AD80-E5E65C43F045Q30482390-4C2525B5-29BA-438F-B5C3-FE7183BBF392Q30572868-F2ADD08B-C422-4846-95BA-39AC621AC628Q30855619-B16C9D86-BE35-41C6-8412-48BB11D09E77Q32169567-47396296-104A-45EC-BD0C-BE886C2DA68DQ33246994-10AE6483-12D0-4E18-BA7F-02057D6182C9Q34249349-F54B2F2D-31E3-4CDF-B221-7B25E9C35B6DQ34286573-343775B0-E336-4D40-9BB1-9C0A4ECBFB1FQ34300600-B7FD1809-82EC-4C03-A3CE-8179AF02D73FQ34328523-C5C75CB0-97B1-4CC1-B76D-38E174C7C45CQ34347257-FD5A1A11-D3EB-44BD-A656-7B2D9709A3B3Q34402998-6BCAE200-45FE-40AC-A354-75026E332220Q34485453-B09CF806-F24D-405A-8000-245FB90BDAD0Q35094559-B3152973-F9AF-4F6E-97DD-6FEFF5EC03BCQ35764703-3A3633D4-21D1-4615-B5B5-E71DBB2BCD5AQ35821578-1A7384EB-A461-4E9A-AC53-BDC0EF5CECC2Q35843084-1D3872B2-B32C-4BE4-BE9C-89EFBCACE311Q35976494-BE7CD90F-899E-4049-BB14-E75FA414E4B4Q35991692-AC0EF55E-3F79-445D-A71E-7E7985B9BC40Q35992104-BB0B6A50-695F-40C5-A6DF-EE927EB7400EQ36047193-5AEE6A53-37DF-4A32-85F6-F776681E8E00Q36081582-D7DAFCB1-EC97-459D-B46F-8E58588A829FQ36114948-9ED011D8-58C1-4A3B-9DA9-DE05ADF0901BQ36115522-6CE5FC24-01BE-4949-B250-916CF80F9623Q36136483-BED2588E-DDED-417F-9C3A-E7F2414A6E32Q36292142-46EFA820-26A6-4390-852D-8DA671585C8FQ36309599-31C0A94B-B738-4C81-8566-C8E377E5B3BEQ36370362-775F0E49-B201-4347-AE01-E29785474B93Q36528193-BDBC209F-F98A-4D5F-88F2-FEEC07E4A15CQ36640851-8DE77732-94F4-448C-9699-F26154F97470Q36641944-1716BFCB-7452-43B6-867C-3DE75FD3C215Q36643664-D2E50DD6-518F-414A-B8A9-2690B1C63B0AQ36648697-CA223A8E-961A-4609-9C62-48FB196184CBQ36670906-06A8BB84-CDF0-4213-9919-0998209D4739Q36678044-6E49D293-1F91-4E66-82C9-8F4C6D8E3B05Q36721579-5022DC7C-A7CB-49E2-AB86-30DF5CEACB4AQ36724659-4269A7D8-190A-4968-9D08-CF56FBC6CACEQ36843901-E135BECD-7870-4EE7-AE10-46BBB5B5C68EQ36980838-20014105-2791-4050-BE41-A0F14469FDABQ37004553-33A1C5DC-39BA-4588-AA7B-7266B2017F50
P50
description
norsk forsker
@nb
name
Einar K. Rofstad
@ast
Einar K. Rofstad
@da
Einar K. Rofstad
@de
Einar K. Rofstad
@en
Einar K. Rofstad
@fr
Einar K. Rofstad
@nb
Einar K. Rofstad
@nl
Einar K. Rofstad
@nn
Einar K. Rofstad
@sl
Einar K. Rofstad
@sq
type
label
Einar K. Rofstad
@ast
Einar K. Rofstad
@da
Einar K. Rofstad
@de
Einar K. Rofstad
@en
Einar K. Rofstad
@fr
Einar K. Rofstad
@nb
Einar K. Rofstad
@nl
Einar K. Rofstad
@nn
Einar K. Rofstad
@sl
Einar K. Rofstad
@sq
altLabel
E K Rofstad
@en
E Rofstad
@en
E. K. Rofstad
@en
E. Rofstad
@en
Einar K Rofstad
@en
Einar Kåre Rofstad
@nb
Einar Rofstad
@en
Rofstad E
@en
Rofstad E. K.
@en
Rofstad E.
@en
prefLabel
Einar K. Rofstad
@ast
Einar K. Rofstad
@da
Einar K. Rofstad
@de
Einar K. Rofstad
@en
Einar K. Rofstad
@fr
Einar K. Rofstad
@nb
Einar K. Rofstad
@nl
Einar K. Rofstad
@nn
Einar K. Rofstad
@sl
Einar K. Rofstad
@sq